Purinergic Receptor P2Y12-Mediated Tau Internalization in Microglia

Hariharakrishnan Chidambaram1,2, Smita Eknath Desale1,2, Subashchandrabose Chinnathambi3,4,5

  • 1Neurobiology Group, Division of Biochemical Sciences, CSIR-National Chemical Laboratory, Pune, India.

Insights

Microglia, the brain's immune cells, become overactive in Alzheimer's disease. The P2Y12 receptor on microglia mediates the uptake and degradation of toxic Tau species, a key process in neurodegeneration.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia are crucial for brain surveillance and function as resident macrophages.
  • In Alzheimer's disease (AD), microglia become dysregulated due to amyloid-β and Tau accumulation, contributing to neurodegeneration.
  • Extracellular Tau species are implicated in microglial activation and AD pathogenesis.

Purpose of the Study:

  • To investigate the role of the P2Y12 receptor in microglial uptake of extracellular Tau.
  • To elucidate the mechanism of P2Y12 receptor-mediated Tau internalization and degradation.
  • To understand how P2Y12 receptor signaling influences microglial responses to Tau.

Main Methods:

  • Utilized cell culture models of microglia and Tau pathology.
  • Investigated P2Y12 receptor expression and localization upon Tau exposure.
  • Employed techniques to track Tau internalization, intracellular trafficking, and degradation.
  • Analyzed P2Y12 receptor's role in actin remodeling and microglial migration.

Main Results:

  • Extracellular Tau directly activates microglia via interaction with the P2Y12 receptor.
  • The Tau-P2Y12 receptor complex undergoes internalization and subsequent lysosomal degradation.
  • P2Y12 receptor signaling is involved in actin remodeling, essential for microglial migration and phagocytosis.
  • This mechanism highlights a specific pathway for microglia to clear extracellular Tau.

Conclusions:

  • P2Y12 receptor-mediated internalization is a significant mechanism for microglia to phagocytose extracellular Tau.
  • Targeting the P2Y12 receptor pathway could offer therapeutic strategies for Alzheimer's disease by modulating microglial responses to Tau.

Related Concept Videos